Arvinas, Inc.

Arvinas, Inc. is a clinical-stage biotechnology company specializing in targeted protein degradation therapeutics using PROTAC technology. They focus on developing innovative treatments for oncology and neurology, aiming to transform drug discovery and improve patient outcomes.